tirzepatide heart racing Why Does GLP-1 Increase Rate? Mechanisms and Management Can Tirzepatide Cause Heart Palpitations?

Further optimization of fermentation strategies may enhance production efficiency and expand the industrial applicability of this system

In a clinical trial in pediatric patients aged 12 years and older with normal baseline heart rate, more patients treated with WEGOVY compared to placebo had maximum changes in heart rate of 20 bpm or more (54% versus 39%) [see Adverse Reactions (6.1)]

Contributions of Drug Transporters to Blood-Placental Barrier

G., Schlee, M., Coch, C

To address this gap, our study investigates whether GLP-1 RA therapy influences the incidence of legal blindness and ION in a propensity-matched cohort of T2DM patients with underlying cardiovascular risk factors